The driving factor for the growth of the population health management market includes the rise in necessity to opt for cost-effective treatment options, increasing adoption of healthcare information technology (HCIT), and disease management programs by public and private insurance providers. The growing geriatric population and the increase in the prevalence of chronic diseases requiring proper health management also drive the growth of the market.

Request for Sample Copy of this Research Report at:
https://www.vynzresearch.com/healthcare/population-health-management-market/request-sample

The industry on the basis of offering is categorized into software and services, where services are expected to witness high demand and projected to observe faster growth during the forecast period. Based on end-user, the market is categorized into healthcare payers, healthcare providers, government bodies, and employer group. Healthcare providers register to hold the largest market share of more than 80% in 2017, due to the reduced healthcare management gap as a result of population health management solutions, mainly to the high-risk pool of patients.

Europe is the second-largest market in the global population health management industry, whereas Asia-Pacific is expected to witness significant growth at a high CAGR of 27.4% during the forecast period. The growth is driven by the rising geriatric population base and increasing prevalence of chronic diseases. The region has also witnessed increased healthcare expenditure to improve the healthcare infrastructure and government initiatives for disease management programs that will drive the region growth in the global market by 2024.

Explore Full Research Report Description at: https://www.vynzresearch.com/healthcare/population-health-management-market

Some of the leading players of the global population health management market include McKesson Corporation, Cerner Corporation, Health Catalyst, LLC, Wellcentive, Inc., Conifer Health Solutions, LLC, Allscripts Healthcare Solutions, Inc., Verscend Technologies, Inc., UnitedHealth Group, and IBM Corporation.

Source: VynZ Research